Skip to content

PTSD

Can TMS Help With Combat-Related PTSD? What a New Trial Means

A randomized trial suggests that navigated TMS may strengthen the effects of intensive trauma therapy for combat-related PTSD. The result is encouraging, but it does not show that TMS works as a stand-alone treatment or is suitable for everyone.

Written by Dr. Chi Hung Au, Psychiatrist

4 min read

The short answer

Transcranial magnetic stimulation (TMS) may have a role in treating combat-related post-traumatic stress disorder (PTSD), particularly when used alongside structured trauma therapy. In the randomized trial discussed here, active navigated TMS added to intensive residential trauma treatment reduced PTSD symptoms more than sham TMS.

This is an encouraging result, but it needs to be interpreted carefully. The study evaluated a combined treatment program, so it does not establish TMS as an effective stand-alone treatment for PTSD. It also does not mean that every TMS approach will produce the same results.

What did the trial test?

The researchers compared active TMS with sham TMS, which was designed to resemble treatment without delivering the same therapeutic stimulation. Both groups also received intensive residential trauma therapy.

This design helps researchers estimate whether adding active TMS provides benefit beyond the broader treatment program and the experience of receiving a procedure. The active-TMS group showed greater improvement in combat-related PTSD symptoms than the sham group.

The key point is that TMS was an addition to comprehensive trauma care. The trial did not compare TMS alone with trauma-focused psychotherapy alone, and its results should not be read that way.

What is navigated TMS?

TMS is a non-invasive treatment that uses magnetic pulses to stimulate selected brain regions. Treatment is delivered while the patient is awake, without surgery or a general anaesthetic.

“Navigated” TMS uses imaging or positioning technology to help identify and consistently target a planned treatment area. That added precision does not mean all navigated protocols are equivalent. Outcomes can depend on the brain target, stimulation pattern, treatment schedule and condition being treated.

What the findings do—and do not—tell us

The trial supports further study of TMS as an adjunct to trauma-focused treatment. It does not establish a universal PTSD protocol or prove that benefits will persist over the long term.

Research findings from a specialized residential program may also not transfer directly to routine outpatient care. Participants in clinical trials are selected according to specific criteria, and real-world patients often have different medical histories, symptoms and co-occurring conditions.

  • The result is promising, not definitive.
  • The evidence applies to the protocol and treatment setting that were studied.
  • It does not show that TMS should replace established trauma-focused care.
  • Response varies, and some people may experience little or no benefit.
  • Further research is needed to clarify durability, optimal treatment parameters and which patients are most likely to benefit.

Is TMS appropriate for someone with PTSD?

That question requires an individualized clinical assessment. PTSD can occur alongside depression, anxiety, sleep problems, substance use or physical health conditions, and these factors can affect treatment planning.

A specialist assessment should review the person’s diagnosis, current symptoms, previous treatments, medications, medical history and goals. It should also explain the expected treatment burden, uncertainties, alternatives and potential adverse effects before a decision is made.

TMS is generally delivered as a series of outpatient appointments. Common treatment experiences and risks should be discussed for the specific protocol under consideration; suitability cannot be determined from an article or symptom checklist.

What this means for veterans on Vancouver Island

For veterans and others living with trauma-related symptoms, this research adds to the developing evidence on brain-stimulation treatments for PTSD. It does not replace a comprehensive assessment or establish that TMS will be recommended in a particular case.

Coverage and authorization requirements through Veterans Affairs Canada, Medavie Blue Cross or other insurers can vary. Eligibility, required documentation and approval should be confirmed directly rather than assumed.

NeuroLinks provides specialist psychiatric assessment and TMS in Nanaimo for appropriately selected patients. To ask whether an assessment may be suitable, contact the clinic or speak with your existing health-care provider. Please do not send confidential clinical details through public website forms unless the form is specifically designed to receive them securely.

References

  1. Peter T. Fox, Felipe S. Salinas, John D. Roache, Marlon Quinones, Phillip W. Vaughan, Crystal Franklin, et al.. Residential Therapy With Navigated Transcranial Magnetic Stimulation for Combat-Related PTSD. JAMA Network Open 9(4):e265110 (2026)

This article is educational and does not replace an individual psychiatric assessment. Medical review is recorded in the article details when completed.